Research programme: enterovirus A vaccine - Chongqing Zhifei Biological Products

Drug Profile

Research programme: enterovirus A vaccine - Chongqing Zhifei Biological Products

Alternative Names: E71 vaccine - Chongqing Zhifei Biological Products; Enterovirus A infection vaccine - Chongqing Zhifei Biological Products; Hand, foot and mouth disease (HFMD) vaccine - Chongqing Zhifei Biological Products; HFMD vaccine - Chongqing Zhifei Biological Products

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chongqing Zhifei Biological Products
  • Class Enterovirus vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Enterovirus A infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Enterovirus A infections in China
  • 04 Jun 2013 Changed profile name from 'Research programme: enterovirus 71 vaccine - Chongqing Zhifei Biological Products' to 'Research programme: enterovirus A vaccine - Chongqing Zhifei Biological Products'. Added drug class: Enterovirus vaccines.
  • 03 Oct 2012 Preclinical trials in Enterovirus infections in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top